EPSTEIN-BARR VIRUS KIT
epstein-barr virus nosode kit |
Product Information |
Product Type | HUMAN OTC DRUG | Item Code (Source) | NDC: 43742-0872 |
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 43742-0872-1 | 1 in 1 CARTON | 05/27/2016 | |
1 | | 1 in 1 DOSE PACK; Type 1: Convenience Kit of Co-Package | | |
|
Quantity of Parts |
Part # | Package Quantity | Total Product Quantity |
Part 1 | 1 VIAL, SINGLE-DOSE | 2 mL |
Part 2 | 1 VIAL, SINGLE-DOSE | 2 mL |
Part 3 | 1 VIAL, SINGLE-DOSE | 2 mL |
Part 4 | 1 VIAL, SINGLE-DOSE | 2 mL |
Part 5 | 1 VIAL, SINGLE-DOSE | 2 mL |
Part 6 | 1 VIAL, SINGLE-DOSE | 2 mL |
Part 7 | 1 VIAL, SINGLE-DOSE | 2 mL |
Part 8 | 1 VIAL, SINGLE-DOSE | 2 mL |
Part 9 | 1 VIAL, SINGLE-DOSE | 2 mL |
Part 10 | 1 VIAL, SINGLE-DOSE | 2 mL |
|
Part 1 of 10 |
EPSTEIN-BARR VIRUS
epstein-barr virus nosode liquid |
|
Product Information |
Item Code (Source) | NDC: 43742-0873 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (HUMAN HERPESVIRUS 4 - UNII:2A26YW7PNX) | HUMAN HERPESVIRUS 4 | 15 [hp_X] in 1 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 43742-0873-1 | 2 mL in 1 VIAL, SINGLE-DOSE; Type 1: Convenience Kit of Co-Package | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved homeopathic | | | |
|
Part 2 of 10 |
EPSTEIN-BARR VIRUS
epstein-barr virus nosode liquid |
|
Product Information |
Item Code (Source) | NDC: 43742-0874 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (HUMAN HERPESVIRUS 4 - UNII:2A26YW7PNX) | HUMAN HERPESVIRUS 4 | 20 [hp_X] in 1 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 43742-0874-1 | 2 mL in 1 VIAL, SINGLE-DOSE; Type 1: Convenience Kit of Co-Package | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved homeopathic | | | |
|
Part 3 of 10 |
EPSTEIN-BARR VIRUS
epstein-barr virus nosode liquid |
|
Product Information |
Item Code (Source) | NDC: 43742-0875 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (HUMAN HERPESVIRUS 4 - UNII:2A26YW7PNX) | HUMAN HERPESVIRUS 4 | 30 [hp_X] in 1 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 43742-0875-1 | 2 mL in 1 VIAL, SINGLE-DOSE; Type 1: Convenience Kit of Co-Package | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved homeopathic | | | |
|
Part 4 of 10 |
EPSTEIN-BARR VIRUS
epstein-barr virus nosode liquid |
|
Product Information |
Item Code (Source) | NDC: 43742-0876 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (HUMAN HERPESVIRUS 4 - UNII:2A26YW7PNX) | HUMAN HERPESVIRUS 4 | 60 [hp_X] in 1 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 43742-0876-1 | 2 mL in 1 VIAL, SINGLE-DOSE; Type 1: Convenience Kit of Co-Package | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved homeopathic | | | |
|
Part 5 of 10 |
EPSTEIN-BARR VIRUS
epstein-barr virus nosode liquid |
|
Product Information |
Item Code (Source) | NDC: 43742-0877 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (HUMAN HERPESVIRUS 4 - UNII:2A26YW7PNX) | HUMAN HERPESVIRUS 4 | 90 [hp_X] in 1 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 43742-0877-1 | 2 mL in 1 VIAL, SINGLE-DOSE; Type 1: Convenience Kit of Co-Package | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved homeopathic | | | |
|
Part 6 of 10 |
EPSTEIN-BARR VIRUS
epstein-barr virus nosode liquid |
|
Product Information |
Item Code (Source) | NDC: 43742-0878 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (HUMAN HERPESVIRUS 4 - UNII:2A26YW7PNX) | HUMAN HERPESVIRUS 4 | 120 [hp_X] in 1 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 43742-0878-1 | 2 mL in 1 VIAL, SINGLE-DOSE; Type 1: Convenience Kit of Co-Package | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved homeopathic | | | |
|
Part 7 of 10 |
EPSTEIN-BARR VIRUS
epstein-barr virus nosode liquid |
|
Product Information |
Item Code (Source) | NDC: 43742-0879 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (HUMAN HERPESVIRUS 4 - UNII:2A26YW7PNX) | HUMAN HERPESVIRUS 4 | 150 [hp_X] in 1 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 43742-0879-1 | 2 mL in 1 VIAL, SINGLE-DOSE; Type 1: Convenience Kit of Co-Package | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved homeopathic | | | |
|
Part 8 of 10 |
EPSTEIN-BARR VIRUS
epstein-barr virus nosode liquid |
|
Product Information |
Item Code (Source) | NDC: 43742-0880 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (HUMAN HERPESVIRUS 4 - UNII:2A26YW7PNX) | HUMAN HERPESVIRUS 4 | 200 [hp_X] in 1 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 43742-0880-1 | 2 mL in 1 VIAL, SINGLE-DOSE; Type 1: Convenience Kit of Co-Package | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved homeopathic | | | |
|
Part 9 of 10 |
EPSTEIN-BARR VIRUS
epstein-barr virus nosode liquid |
|
Product Information |
Item Code (Source) | NDC: 43742-0881 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (HUMAN HERPESVIRUS 4 - UNII:2A26YW7PNX) | HUMAN HERPESVIRUS 4 | 500 [hp_X] in 1 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 43742-0881-1 | 2 mL in 1 VIAL, SINGLE-DOSE; Type 1: Convenience Kit of Co-Package | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved homeopathic | | | |
|
Part 10 of 10 |
EPSTEIN-BARR VIRUS
epstein-barr virus nosode liquid |
|
Product Information |
Item Code (Source) | NDC: 43742-0882 |
Route of Administration | ORAL |
|
Active Ingredient/Active Moiety |
Ingredient Name | Basis of Strength | Strength |
HUMAN HERPESVIRUS 4 (UNII: 2A26YW7PNX) (HUMAN HERPESVIRUS 4 - UNII:2A26YW7PNX) | HUMAN HERPESVIRUS 4 | 1000 [hp_X] in 1 mL |
|
|
|
Packaging |
# | Item Code | Package Description | Marketing Start Date | Marketing End Date |
1 | NDC: 43742-0882-1 | 2 mL in 1 VIAL, SINGLE-DOSE; Type 1: Convenience Kit of Co-Package | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved homeopathic | | | |
|
|
Marketing Information |
Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
unapproved homeopathic | | 05/27/2016 | |
|